Our weekly roundup of the latest science in the news, as well as a few fascinating articles to keep you entertained over the ...

The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

Scientists have used artificial intelligence (AI) to design never-before-seen nanomaterials with the strength of carbon steel ...

The gigantic coronal hole is blasting high-speed solar wind toward Earth, potentially igniting vibrant auroras and minor ...

Overall, AI experts say that DeepSeek's popularity is likely a net positive for the industry, bringing exorbitant resource ...

Rather than helping each other out when they're attacked, plants may have to eavesdrop on each other to know when to launch ...

Alexander the Great died at age 32, but his cause of death is unclear. What killed him has been a long-standing source of ...

The Rašaška site is part of the larger settlement of Bobare, which was owned in the early Middle Ages by the Knights Templar, ...

The new study reinforces warnings from doctors about abortion laws with limited or no exceptions.

Neurotechnology raises many high-stakes ethical questions. Setting ground rules could help protect workers and ensure that tasks are adapted to the person, rather than the other way around.

Upheaval Dome is a giant rock formation in southeastern Utah with two potential origin stories, although most scientists think it was created by an ancient meteor strike.

A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with severe depression, the FDA says. Here's what that means.